Boehringer sells drug safety software to ArisGlobal
pharmaphorum
MAY 12, 2022
The software can be used to conduct an initial analysis of adverse reactions to medications that have already been approved to identify potential side effects and undesirable events, and provides a decision-making tool for those working in pharmacovigilance, helping them process each case more quickly.
Let's personalize your content